Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAPed
2023-507510-27-00Phase 4Completed
- Sponsor
- Dicofarm
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of Ibuprofen L-lysine and ibuprofen in acute pain (2 arms), sponsored by Dicofarm. Started Jan 2024; status: completed.
02
Drugs
Ibuprofen L-lysineibuprofen
03
Conditions
acute pain
Beyond the preview
Go deeper on 2023-507510-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507510-27-00.